Cathay Biotech Inc., headquartered in Shanghai and listed on the Shanghai STAR Market (688065.SH), specializes in the research, development, production, and sales of bio-based materials leveraging synthetic biology and bio-manufacturing technology. Established in 2000, the company operates two R&D centers and three production sites in China, focusing on products such as bio-based polyamides PA5X and monomers like long-chain diacids and pentamethylene diamine, serving industries including nylon, polymer compounding, textiles, and automotive.
No recent deals for this company.